- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06318611
Sleep Patterns and Chronotype in Children With and Without Type 1 Diabetes
Sleep Patterns and Chronotype Among Children and Adolescents With Type 1 Diabetes Compared to Case-control Peers Without Diabetes
Type 1 diabetes (T1D) is one of the most common chronic childhood diseases. Recent studies have highlighted the strong association between type 1 diabetes and sleep health problems. Sleep problems have been reported to include sleep onset, sleep maintenance, frequent nighttime awakenings, and daytime sleepiness. Studies show that children with T1D sleep significantly less than their peers without diabetes, and that this is associated with poorer glycemic control in type 1 diabetes due to impaired glucose metabolism.
This study aimed to compare sleep health composite dimensions and chronotype in children and adolescents with and without T1D, and to explore the relationship between sleep and glycemic variability in T1D.
The study was designed as a prospective observational case-control study. The estimated sample size is calculated as 168.
The sleep health composite dimensions were measured using actigraphy, sleep diaries, and self- or parental reports. Sleep disturbance will be assessed using the Diagnostic and Statistical Manual for Mental Disorders (DSM-5) Level 2-Sleep Disturbance Scale Short Form, and the Children's Chronotype Questionnaire will be used to determine the chronotype. Sleep/wake patterns were also assessed using sleep diaries. Glycemic variability was assessed using continuous glucose monitoring (CGM) device parameters.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Type 1 diabetes (T1D) is one of the most common chronic diseases in childhood. The prevalence of T1D in Turkey is reported to be 0.75%. Recent studies draw attention to the close relationship between type 1 diabetes and sleep problems. It has been suggested that sleep duration is insufficient and sleep quality is impaired in patients with T1D. Sleep problems have been reported to include sleep onset, sleep maintenance, frequent nighttime awakenings, and daytime sleepiness. Conditions such as nocturnal glycemic variability and fear of hypoglycemia specific to patients with T1D, alarms from devices such as continuous glucose monitors and pumps used in diabetes management, anxiety, stress and depressive symptoms associated with diabetes, and treatment that may sometimes last throughout the night are possible factors that adversely affect the sleep health of people with diabetes. Studies show that children with T1D sleep significantly less than their peers without diabetes and that this is associated with poorer glycemic control in type 1 diabetes due to impaired glucose metabolism. The American Diabetes Association (ADA) has emphasized that sleep health should be included in the routine assessment of people with diabetes by 2022.
This study aimed to compare sleep health composite dimensions and chronotype in children and adolescents with and without T1D, and to explore the relationship between sleep and glycemic variability in T1D.
The study was designed as a prospective observational case-control study. The estimated sample size is calculated as 168.
The sleep health composite dimensions were measured using actigraphy, sleep diaries, and self- or parental reports. This composite evaluates various dimensions of sleep, including regularity, satisfaction, alertness, timing, efficiency, and duration. Each dimension is assigned a code of '1' for 'good' and '0' for 'poor.' The sleep health composite is designed so that a higher score indicates better overall sleep health.
Sleep disturbances were assessed using the DSM-5 Level 2-Sleep Disturbance Scale Short Form. The DSM-5 Level 2-Sleep Disorders Scale short form was used to evaluate sleep disturbances. It is an 8-item scale that specifically evaluates sleep disorders in children and adolescents, within the past 7 days. Each item is rated on a 5-point scale (1=never; 2=rarely; 3=sometimes; 4=often, and 5=always). The total score ranges from 8 to 40 points, with higher scores indicating more severe sleep disturbances. Sleep/wake patterns were also assessed using sleep diaries.
The Childhood Chronotype Questionnaire was used to evaluate the chronotype in children. This 27-item questionnaire was developed for Turkish children in the light of the Munich Chronotype Questionnaire and the Mornings-Evenings Questionnaire. The chronotypes were classified as morning, intermediate and evening types, corresponding scores of ≤23, 24-32 and ≥33. The child form of the Childhood Chronotype Questionnaire was completed by the parent and the adolescent form was completed by the adolescent.
Glycemic variability was assessed using continuous glucose monitoring (CGM) device parameters. Glycemic variability was evaluated using the J index to assess the effectiveness of glycemic control (calculated as 0.001 × (mean + SD)), the low blood glucose index (LBGI) to evaluate the risk of hypoglycemia, the high blood glucose index (HBGI) to determine the likelihood of hyperglycemia, and the Coefficient of Variation (CV). The Coefficient of Variation expresses the percentage variation in blood glucose levels, with a CV ≤36% indicating a stable glucose profile and a CV >36% indicating an unstable glucose profile. For 24-hour continuous glucose monitoring, the targeted percentages of time were >70% at 70-180 mg/dl for glycemic control, <4% at <70 mg/dl for hypoglycemia, <1% at <54 mg/dl for severe hypoglycemia, <25% at >180 mg/dl for hyperglycemia and <5% at >250 mg/dl for severe hyperglycemia. The hemoglobin A1c level is also used for glycemic control.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
İstanbul, Turkey, 34010
- Necla İpar
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Aged between 6 to 18 years
- Use of continuous glucose monitor system
Exclusion Criteria:
- Acute medical condition that can impact sleep (diabetic ketoacidosis, cold, influenza)
- Diagnosed neurodevelopmental or behavioral conditions like autism spectrum disorder or Attention Deficit/Hyperactivity Disorder
- Diagnosed sleep disorder (Obstructive Sleep Apnea)
- Current use of medications that can impact sleep (diphenhydramine)
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Case group
Children and adolescents diagnosed with type 1 diabetes aged between 6 to 18 years
|
Our objectives were to compare sleep health composite dimensions, and chronotype in children and adolescents with and without T1D, and to explore relationship between sleep and glycemic variability in T1D.
|
Control group
Children and adolescents without type 1 diabetes between the ages of 6 and 18.
|
Our objectives were to compare sleep health composite dimensions, and chronotype in children and adolescents with and without T1D, and to explore relationship between sleep and glycemic variability in T1D.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Sleep health composite
Time Frame: Prospective, up to 24 weeks
|
The sleep health composite dimensions were measured using actigraphy, sleep diaries, and self- or parental reports.
This composite evaluates various dimensions of sleep, including regularity, satisfaction, alertness, timing, efficiency, and duration.
Sleep disturbances were assessed using the DSM-5 Level 2-Sleep Disturbance Scale Short Form.
The DSM-5 Level 2-Sleep Disorders Scale short form was used to evaluate sleep disturbances.
It is an 8-item scale that specifically evaluates sleep disorders in children and adolescents within the past 7 days.
Each item is rated on a 5-point scale (1=never; 2=rarely; 3=sometimes; 4=often, and 5=always).
The total score ranges from 8 to 40 points, with higher scores indicating more severe sleep disturbances.
|
Prospective, up to 24 weeks
|
Chronotype
Time Frame: Prospective, up to 24 weeks
|
Chronotype was evaluated by the Children's Chronotype Questionnaire.
The Childhood Chronotype Questionnaire was used to evaluate the chronotype in children.
This 27-item questionnaire was developed for Turkish children in the light of the Munich Chronotype Questionnaire and the Mornings-Evenings Questionnaire.
The chronotypes were classified as morning, intermediate and evening types, corresponding scores of ≤23, 24-32 and ≥33.
The child form of the Childhood Chronotype Questionnaire was completed by the parent and the adolescent form was completed by the adolescent.
|
Prospective, up to 24 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Glycemic variability
Time Frame: Prospective, up to 24 weeks
|
Glycemic variability was assessed using continuous glucose monitoring device parameters.
Glycemic variability was evaluated using the J index to assess the effectiveness of glycemic control, the low blood glucose index (LBGI) to evaluate the risk of hypoglycemia, the high blood glucose index (HBGI) to determine the likelihood of hyperglycemia, and the Coefficient of Variation.
|
Prospective, up to 24 weeks
|
Glycemic control
Time Frame: Prospective, up to 24 weeks
|
For 24-hour continuous glucose monitoring, the targeted percentages of time were >70% at 70-180 mg/dl for glycemic control, <4% at <70 mg/dl for hypoglycemia, <1% at <54 mg/dl for severe hypoglycemia, <25% at >180 mg/dl for hyperglycemia and <5% at >250 mg/dl for severe hyperglycemia.
The hemoglobin A1c level is also used for glycemic control.
|
Prospective, up to 24 weeks
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 09.2022.575
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Type1diabetes
-
Silesian Centre for Heart DiseasesThe Jerzy Kukuczka Academy of Physical Education in KatowiceCompletedtype1diabetesPoland
-
Vastra Gotaland RegionCompletedType1diabetesSweden
-
Rabin Medical CenterThe Leona M. and Harry B. Helmsley Charitable Trust; DreaMed DiabetesRecruiting
-
The Hospital for Sick ChildrenCanadian Institutes of Health Research (CIHR)Completed
-
University of Southern CaliforniaThe Leona M. and Harry B. Helmsley Charitable TrustCompletedType1diabetesUnited States
-
Aalborg University HospitalAalborg University; Steno Diabetes Center NordjyllandCompletedType1diabetes | Hemodialysis | Type2DiabetesDenmark
-
Vastra Gotaland RegionRecruitingType1diabetes | Psychology Functional BehaviorSweden
-
Radboud University Medical CenterUnknownType1diabetes | Hypoglycemia UnawarenessNetherlands
-
University of PennsylvaniaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National...Active, not recruitingHypoglycemia | Type1diabetes | Islet Cell Transplantation | Hypoglycemia UnawarenessUnited States
-
University of British ColumbiaJuvenile Diabetes Research Foundation; Brain CanadaNot yet recruiting
Clinical Trials on sleep, chronotype
-
Istanbul Medipol University HospitalCompleted
-
University of Nevada, Las VegasCompletedMigraine DisordersUnited States
-
Universidad Católica San Antonio de MurciaHospital Universitario Virgen de la ArrixacaCompleted
-
University of PittsburghNational Heart, Lung, and Blood Institute (NHLBI)RecruitingSleep | Obesity, Childhood | Binge Eating | Self-regulationUnited States
-
Mats LekanderStockholm UniversityCompleted
-
University of CopenhagenCompleted
-
Mayo ClinicNational Heart, Lung, and Blood Institute (NHLBI)Completed
-
University of ChicagoRecruitingOverweight or ObesityUnited States
-
Institut de Recherche Biomedicale des ArmeesUniversity of Paris 5 - Rene Descartes; Hotel Dieu de France HospitalNot yet recruitingCognitive Impairment | Sleep Deprivation